Zhu Y - Search Results

1

A better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivo.

Wang H, Li W, Lai B, Yang X, Zhang C, Li J, Zhu Y. Wang H, et al. Among authors: zhu y. Anticancer Drugs. 2015 Sep;26(8):852-9. doi: 10.1097/CAD.0000000000000259. Anticancer Drugs. 2015. PMID: 26164152 Free PMC article.

2

Role of 3' repressor sequences of p53 in anti-cancer drug sensitivity of human lung tumor cells.

Wang H, Li W, Lai B, Yang X, Zhang C, Tao H, Zhu Y, Li J. Wang H, et al. Among authors: zhu y. Gene. 2016 Dec 15;594(2):190-196. doi: 10.1016/j.gene.2016.08.053. Epub 2016 Sep 1. Gene. 2016. PMID: 27591972

3

[Effects of p53 gene on drug resistance in human lung cancer cell lines.].

Tao H, Zhu Y, Wang H, Lai B, Zhang C, Zhan X, Wang Y, Yang X, Yue W, Zhang H. Tao H, et al. Among authors: zhu y. Zhongguo Fei Ai Za Zhi. 2008 Apr 20;11(2):157-64. doi: 10.3779/j.issn.1009-3419.2008.02.001. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20731894 Free article. Chinese.

4

[Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer].

Li X, Li B, Lai B, Zhang X, Ge Q, Zhan X, Wang Y, Zhu Y. Li X, et al. Among authors: zhu y. Zhongguo Fei Ai Za Zhi. 2007 Apr 20;10(2):138-40. doi: 10.3779/j.issn.1009-3419.2007.02.13. Zhongguo Fei Ai Za Zhi. 2007. PMID: 21114938 Free article. Chinese.

5

[The relationship between EGFR mutations and response and prognosis of tyrosine kinase inhibitors in advanced Non-small-cell Lung Cancer.].

Zhang X, Xu L, Wang H, Zhu Y, Liu Z, Yue W, Tang J, Wu W, Liu Z, Wu Y, Zhang C, Shi Y, Wang M, Shi H, Li M, Meng Q, Guo L, Wang J, Li X. Zhang X, et al. Among authors: zhu y. Zhongguo Fei Ai Za Zhi. 2008 Apr 20;11(2):206-13. doi: 10.3779/j.issn.1009-3419.2008.02.016. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20731903 Free article. Chinese.

6

Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens: a multicenter, randomized, crossover phase 3 study.

Shi YK, Chen Q, Zhu YZ, He XH, Wang HQ, Jiang ZF, Chang JH, Liu YP, Wang AL, Luo DY, Zhang Y, Ke XY, Li WL, Zhang WJ, Wang XW, Zhang YP, Wang JM, Liu XQ. Shi YK, et al. Among authors: zhu yz. Anticancer Drugs. 2013 Jul;24(6):641-7. doi: 10.1097/CAD.0b013e3283610b5d. Anticancer Drugs. 2013. PMID: 23571496 Clinical Trial.

7

[Adverse events of afatinib as first-line treatment for five cases of advanced lung adenocarcinoma and review of literature].

Tao H, Guo L, Tang J, Zhu Y, Xu L, Meng Q, Wu W, Li M, Wu W, Tong L, Wu H, Shi L, Liu Z. Tao H, et al. Among authors: zhu y. Zhongguo Fei Ai Za Zhi. 2014 Apr;17(4):342-6. doi: 10.3779/j.issn.1009-3419.2014.04.09. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24758910 Free PMC article. Review. Chinese.

8

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.

Sun Y, Cheng Y, Hao X, Wang J, Hu C, Han B, Liu X, Zhang L, Wan H, Xia Z, Liu Y, Li W, Hou M, Zhang H, Xiu Q, Zhu Y, Feng J, Qin S, Luo X. Sun Y, et al. Among authors: zhu y. BMC Cancer. 2016 Apr 9;16:265. doi: 10.1186/s12885-016-2301-6. BMC Cancer. 2016. PMID: 27061082 Free PMC article. Clinical Trial.

9

Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer.

Wu YL, Lu S, Cheng Y, Zhou C, Wang M, Qin S, Lu Y, Zhang Y, Zhu Y, Song X, Wang X, Barraclough H, Zhang X, Chi H, Orlando M. Wu YL, et al. Among authors: zhu y. Lung Cancer. 2014 Sep;85(3):401-7. doi: 10.1016/j.lungcan.2014.07.007. Epub 2014 Jul 17. Lung Cancer. 2014. PMID: 25082564 Clinical Trial.

10

BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.

Zhou C, Wu YL, Chen G, Liu X, Zhu Y, Lu S, Feng J, He J, Han B, Wang J, Jiang G, Hu C, Zhang H, Cheng G, Song X, Lu Y, Pan H, Zheng W, Yin AY. Zhou C, et al. Among authors: zhu y. J Clin Oncol. 2015 Jul 1;33(19):2197-204. doi: 10.1200/JCO.2014.59.4424. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014294 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,777 results

Search Page

Filters